Browse Studies — Arctuva

Observational

A Healthy Weight Intervention for Family Stress During the Early Phases of ALL Treatment: NOURISH-ALL

The purpose of this study is to conduct a single arm pilot of the NOURISH-ALL (Nourishing Our Understanding of Role modeling to Improve Support and Health in A…

ALL, ChildhoodBehavior, Health

Estimated

~$10 – $6,250

University of Kansas Medical CenterNCT06050850

Phase 1

Phase I Trial of Ruxolitinib in Combination With a Pediatric Based-regimen for Adolescents and Young Adults (AYAs) With Ph-like Acute Lymphoblastic Leukemia (ALL)

This study will test if adding ruxolitinib to standard multi-drug chemotherapy regimen will be safe and tolerated in adolescents and young adults with newly di…

Acute Lymphoblastic LeukemiaALL, ChildhoodALL

Estimated

~$10 – $6,250

University of ChicagoNCT03571321

Phase 2

Alpha/Beta T-cell and B-cell Depleted Allogeneic Transplantation (IDE 13641) Followed by Blinatumomab Therapy for High-Risk B-Acute Lymphoblastic Leukemia: A Pilot Study

This trial will assess the feasibility of alpha/beta T-cell and B-cell depleted allogeneic hematopoietic cell transplantation (HCT) followed by blinatumomab th…

B-cell Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-Cell ALL, Childhood

Estimated

~$10 – $6,250

Medical College of WisconsinNCT04746209

Phase 1

CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

The study participant has one of the following blood cancers: acute myelogenous leukemia (AML)/myelodysplastic syndrome (MDS), acute lymphoblastic leukemia (B-…

Hematologic MalignancyALL, ChildhoodAML, Childhood+2 more

Estimated

~$10 – $6,250

St. Jude Children's Research HospitalNCT06326463